INTELLIPACE
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 04 Sept 2025)
What this means for you
Registered since 28 Apr 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88197025
- Registration number
- 6043447
- Mark type
- Stylized text
- Filed
- 16 Nov 2018
- Published for opposition
- 23 Apr 2019
- Registered
- 28 Apr 2020
- Attorney of record
- Michael A. Marrero
Goods and services
- Class 042 — Scientific and technological services: Medical and pharmacological research, namely, conducting clinical trials for others
Owner
- Medpace, Inc., Cincinnati, OH, US
- Medpace, Inc., Cincinnati, OH, US
- Medpace, Inc., Cincinnati, OH, US
Prosecution history
- 04 Sept 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 04 Sept 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 04 Sept 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 28 Apr 2025 — TEAS SECTION 8 & 15 RECEIVED
- 28 Apr 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 28 Apr 2020 — REGISTERED-PRINCIPAL REGISTER
- 25 Mar 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Mar 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Mar 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Mar 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Feb 2020 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 23 Feb 2020 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 23 Feb 2020 — FINAL REFUSAL E-MAILED
- 23 Feb 2020 — SU - FINAL REFUSAL - WRITTEN
- 24 Jan 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED